Cargando…

Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization

This retrospective study evaluated the characteristics and response of subretinal hyperreflective material (SHRM) to anti-vascular endothelial growth factor (VEGF) treatment in eyes with myopic choroidal neovascularization (CNV). The visual acuity (VA) was assessed at 3, 6, and 12 months after initi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chien-Jung, Hsia, Yun, Wang, Shih-Wen, Ma, I.-Hsin, Tsui, Mei-Chi, Hung, Kuo-Chi, Ho, Tzyy-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070346/ https://www.ncbi.nlm.nih.gov/pubmed/37012311 http://dx.doi.org/10.1038/s41598-023-32417-7

Ejemplares similares

Hyperreflective Material in Optical Coherence Tomography Images of Eyes with Myopic Choroidal Neovascularization May Affect the Visual Outcome
por: Mushiga, Yasuaki, et al.
Publicado: (2020)

The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMD
por: Ehlers, Justis P., et al.
Publicado: (2022)

Subretinal hyperreflective material in central serous chorioretinopathy
por: Sahoo, Niroj K, et al.
Publicado: (2020)

Characteristics and treatment response of polypoidal choroidal vasculopathy in highly myopic eyes
por: Huang, Wei-Lun, et al.
Publicado: (2022)

Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study
por: Alex, Divya, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
por: Hsu, Cherng-Ru, et al.
Publicado: (2022)

Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study
por: Tsui, Mei-Chi, et al.
Publicado: (2023)

Clinical Characteristics of Highly Myopic Patients With Asymmetric Myopic Atrophic Maculopathy–Analysis Using Multimodal Imaging
por: Hsia, Yun, et al.
Publicado: (2021)

Comparison of Refractive Outcomes in Patients with Highly Myopic Versus Non-highly Myopic Eyes Undergoing Phacovitrectomy
por: Ma, I-Hsin, et al.
Publicado: (2023)

Correlation of Visual Acuity and Outer Retinal Thickness in Myopic Atrophic Maculopathy: A Retrospective Review
por: Lee, Cheng-Yung, et al.
Publicado: (2023)

Hyperreflective material in patients with non-neovascular pachychoroid disease
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
por: Bhatia, Devangna, et al.
Publicado: (2021)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Spontaneous Resolution of Subretinal Hemorrhage Secondary to Choroidal Osteoma Unassociated with Choroidal Neovascularization
por: Koylu, Mehmet Talay, et al.
Publicado: (2014)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Iatrogenic choroidal neovascularization associated with subretinal gene therapy surgery
por: Price, Kenneth W., et al.
Publicado: (2022)

Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021)

Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri, Leila, et al.
Publicado: (2015)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani, Paolo, et al.
Publicado: (2016)

Correlation of In Vivo and In Vitro Methods in Measuring Choroidal Vascularization Volumes Using a Subretinal Injection Induced Choroidal Neovascularization Model
por: Nie, Chuang, et al.
Publicado: (2015)

Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid
por: Bilgic, Alper, et al.
Publicado: (2021)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Myopic traction maculopathy biomarkers on optical coherence tomography angiography—An overlooked mechanism of visual acuity correction in myopic eyes
por: Wang, Shih-Wen, et al.
Publicado: (2019)

Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads
por: Schmack, Ingo, et al.
Publicado: (2009)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
por: Huang, Chu-Hsuan, et al.
Publicado: (2021)

Optical density changes of subretinal hyperreflective material in age-related macular degeneration after switching therapy from ranibizumab to aflibercept
por: Filik, Armagan, et al.
Publicado: (2022)

The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis
por: Zhang, Ruoshuang, et al.
Publicado: (2016)

Choroidal Morphologic and Vascular Features in Patients With Myopic Choroidal Neovascularization and Different Levels of Myopia Based on Image Binarization of Optical Coherence Tomography
por: Wang, Xinglin, et al.
Publicado: (2022)

Prognostic value of myopic disk deformation in myopic choroidal neovascularization: A 6-year follow-up study
por: Han, Ye Eun, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19
por: Au, Sunny Chi Lik
Publicado: (2020)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization
por: Zhu, Wei, et al.
Publicado: (2023)

Correlation Between Hyperreflective Foci in the Choroid and Choroidal Discoloration in Vogt-Koyanagi-Harada Disease
por: Kim, Young Ho, et al.
Publicado: (2022)

Lycopene inhibits endothelial‐to‐mesenchymal transition of choroidal vascular endothelial cells in laser‐induced mouse choroidal neovascularization
por: Li, Lele, et al.
Publicado: (2023)

A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis
por: Zhang, Han, et al.
Publicado: (2013)

Reliability and reproducibility of a rodent model of choroidal neovascularization based on the subretinal injection of polyethylene glycol
por: Fernandez-Bueno, Ivan, et al.
Publicado: (2019)

Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?
por: Quiroz-Mercado, Hugo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p6bl0dt35jqpgo9qrfg3ae6v54